Clinical Trial Update: Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial [Phase 4]

View source ↗

Summary

A Phase 4 head-to-head trial comparing teriparatide with strontium ranelate in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• Protos (strontium ranelate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED